Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical ApplicationsCambridge University Press, 16. sep. 2021 - 623 sider Long established as the preeminent source in its field, the eagerly anticipated fifth edition of Dr Stahl's essential textbook of psychopharmacology is here! With its use of icons and figures that form Dr Stahl's unique 'visual language', the book is the single most readable source of information on disease and drug mechanisms for all students and mental health professionals seeking to understand and utilize current therapeutics, and to anticipate the future for novel medications. Every aspect of the book has been updated, with the clarity of explanation that only Dr Stahl can bring. The new edition includes over 500 new or refreshed figures, an intuitive color scheme, fourteen new uses for older drugs and eighteen brand new drugs, coverage of Parkinson's Disease Psychosis, behavioural symptoms of dementia, and mixed features in major depressive episodes, and expanded information on the medical uses of cannabis and hallucinogen assisted psychotherapy. |
Indhold
Chemical Neurotransmission | 1 |
Ion Channels as Targets | 51 |
Psychosis Schizophrenia and | 77 |
Targeting Dopamine and Serotonin | 159 |
Mood Disorders and the Neurotransmitter | 244 |
Disorders of Sleep and Wakefulness | 401 |
Andre udgaver - Se alle
Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical ... Stephen M. Stahl Begrænset visning - 2021 |
Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical ... Stephen M. Stahl Begrænset visning - 2021 |
Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical ... Stephen M. Stahl Ingen forhåndsvisning - 2021 |
Almindelige termer og sætninger
5HT2A receptors acetylcholine acid activity ADHD agents allosteric Alzheimer disease amygdala antagonism antagonist antidepressant antipsychotic anxiety disorders autoreceptors axon behavioral benzodiazepines binding properties bipolar depression block blockade brain brexpiprazole cause cell cholinergic chronic circadian circuits clinical cognitive D2 receptors dementia discussed in Chapter dopamine release doses downstream dysfunction efficacy enzyme excitatory full agonist function GABA GABAA receptors gene glutamate glutamate neurons glutamatergic histamine hyperactivity hypothetically impulsivity increased inhibition insomnia ketamine ligand-gated ion channels major depressive mania mechanism of action mesolimbic mixed features monoamine mood disorders motor negative symptoms neurons neurotransmitter nicotinic NMDA receptor norepinephrine normal nucleus opioid orexin pain partial agonist patients pharmacological postsynaptic potential prefrontal cortex presynaptic protein Psychopharmacology psychosis psychotic quetiapine reduce regulate reuptake inhibitors schizophrenia serotonin SERT side effects signal transduction sleep SNRI spectrum SSRIs Stahl SM stimulation striatum subtypes subunits synapse target thalamus therapeutic transporter treat treatment unipolar ventral VMAT2 VSCCs
